Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

PGEN

Precigen Inc

Apr 23 • 12:26PM ET

1.42

Dollar change +0.04
Percentage change 2.90	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN IBB SCHA VTWO IWC SMLF CNCR

Index	RUT	P/E	-	EPS (ttm)	-0.39	Insider Own	50.71%	Shs Outstand	248.92M	Perf Week	4.41%
Market Cap	353.47M	Forward P/E	-	EPS next Y	-0.27	Insider Trans	0.00%	Shs Float	122.70M	Perf Month	1.79%
Income	-95.90M	PEG	-	EPS next Q	-0.09	Inst Own	30.79%	Short Float	13.77%	Perf Quarter	0.71%
Sales	6.22M	P/S	56.83	EPS this Y	13.85%	Inst Trans	-6.87%	Short Ratio	16.49	Perf Half Y	33.96%
Book/sh	0.48	P/B	2.98	EPS next Y	20.83%	ROA	-49.78%	Short Interest	16.90M	Perf Year	16.39%
Cash/sh	0.25	P/C	5.62	EPS next 5Y	2.40%	ROE	-78.37%	52W Range	0.84 - 1.88	Perf YTD	5.97%
Dividend Est.	-	P/FCF	-	EPS past 5Y	36.94%	ROI	-77.10%	52W High	-24.46%	Beta	1.75
Dividend TTM	-	Quick Ratio	2.99	Sales past 5Y	-20.14%	Gross Margin	-58.32%	52W Low	69.98%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	2.99	EPS Y/Y TTM	-20.13%	Oper. Margin	-1428.50%	RSI (14)	51.38	Volatility	6.14% 4.81%
Employees	202	Debt/Eq	0.06	Sales Y/Y TTM	-88.35%	Profit Margin	-1540.63%	Recom	1.80	Target Price	9.00
Option/Short	Yes / Yes	LT Debt/Eq	0.05	EPS Q/Q	-24.69%	Payout	-	Rel Volume	0.38	Prev Close	1.38
Sales Surprise	-42.47%	EPS Surprise	-64.56%	Sales Q/Q	-30.35%	Earnings	Mar 19 AMC	Avg Volume	1.02M	Price	1.42
SMA20	1.85%	SMA50	-2.59%	SMA200	5.30%	Trades		Volume	185,643	Change	2.90%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-22-24	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Initiated	JP Morgan	Neutral
Nov-18-22	Initiated	Cantor Fitzgerald	Overweight	$7
Feb-25-21	Initiated	Stifel	Buy	$13
Feb-22-21	Initiated	Wells Fargo	Overweight	$14
Feb-18-21	Initiated	B. Riley Securities	Buy	$10
May-08-20	Initiated	H.C. Wainwright	Buy	$5

Mar-28-24 04:05PM	Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th (PR Newswire)
Mar-27-24 08:20AM	Analysts on Wall Street Lower Ratings for These 10 Stocks (Insider Monkey)
Mar-20-24 10:07AM	Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-19-24 08:53PM	PGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:31PM	Precigen Inc (PGEN) Reports Full Year 2023 Financial Results (GuruFocus.com)
04:05PM	Loading…
04:05PM	Precigen Reports Full Year 2023 Financial Results and Business Updates (PR Newswire)
Mar-12-24 04:05PM	Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Mar-05-24 04:05PM	Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th (PR Newswire)
Feb-06-24 04:05PM	Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire)
Jan-16-24 08:05AM	Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission (PR Newswire)
Jan-08-24 08:30AM	Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire) +8.53%
Jan-02-24 12:40PM	Hedge Fund and Insider Trading News: David Einhorn, Bill Ackman, D. E. Shaw, Steve Cohen, Rob Citrone, Saba Capital, HighPeak Energy, Inc (HPK), Precigen Inc (PGEN), and More (Insider Monkey) +5.22%
Dec-18-23 04:05PM	Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire) -5.74%
Nov-29-23 04:05PM	Precigen to Participate in the JMP Securities Hematology and Oncology Summit (PR Newswire)
Nov-09-23 04:55PM	Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs (PR Newswire)
04:05PM	Loading…
Nov-07-23 04:05PM	Precigen to Participate in the Stifel 2023 Healthcare Conference (PR Newswire) +12.93%
Sep-19-23 04:05PM	Precigen to Participate in Upcoming Leading Investor and Industry Conferences (PR Newswire) -8.33%
Aug-09-23 08:00AM	Precigen Reports Second Quarter and First Half 2023 Financial Results and Provides Update on Portfolio Prioritization and Capital Allocation Strategies to Extend Projected Cash Runway into 2025 (PR Newswire) +6.90%
07:05AM	Precigen Announces FDA Confirmation that the Ongoing Phase 1/2 Study of PRGN-2012 AdenoVerse Immunotherapy Will Serve as the Pivotal Study to Support Accelerated Approval (PR Newswire)
Aug-03-23 04:05PM	Precigen to Announce Second Quarter and First Half 2023 Financial Results on August 9th (PR Newswire) -6.67%
Jun-20-23 07:30AM	Precigen Receives Breakthrough Therapy Designation for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Jun-05-23 04:05PM	Precigen Announces Positive Phase 1 Data for PRGN-3005 Autologous UltraCAR-T® Cells Manufactured Overnight for Infusion Next Day to Advanced Stage Platinum Resistant Ovarian Cancer Patients (PR Newswire)
Jun-03-23 12:00PM	Precigen Announces Positive Phase 1 Data for Off-the-Shelf PRGN-2009 AdenoVerse Immunotherapy Alone and in Combination with an Investigational Checkpoint Inhibitor in Patients with Recurrent/Metastatic HPV-associated Cancers (PR Newswire)
May-31-23 08:05AM	Precigen Receives FDA Clearance of IND to Initiate Phase 2 Study of PRGN-2009 Off-the-Shelf AdenoVerse Immunotherapy in Combination with Pembrolizumab to Treat Patients with Recurrent or Metastatic Cervical Cancer (PR Newswire)
May-10-23 08:00AM	Precigen Reports First Quarter 2023 Financial Results and Business Updates (PR Newswire)
May-03-23 08:30AM	Precigen to Announce First Quarter 2023 Financial Results on May 10th (PR Newswire) +8.85%
Apr-26-23 04:05PM	Precigen to Present Latest Clinical Advancements for PRGN-3005 UltraCAR-T® and PRGN-2009 Off-the-Shelf AdenoVerse Immunotherapy at the 2023 ASCO Annual Meeting (PR Newswire)
Apr-17-23 09:01AM	Precigen Presents Preclinical Data for the Next Generation Mesothelin UltraCAR-T® with Intrinsic PD-1 Blockade at the AACR Annual Meeting 2023 (PR Newswire) +10.48%
Apr-03-23 04:30PM	Precigen Regains Exclusive Rights to Proven CAR-T Targets, CD19 and BCMA, to Enable Unencumbered Development and Commercialization of UltraCAR-T® (PR Newswire) +5.66%
Mar-29-23 08:05AM	Precigen Announces Further Advancement of UltraCAR-T® Platform with First Patient Dosed in Phase 1/1b Dose Escalation/Dose Expansion Study of PRGN-3007 in Advanced ROR1+ Hematological and Solid Tumors (PR Newswire) +15.44%
08:05AM	Loading…
Mar-28-23 08:05AM	Precigen to Participate in a Virtual Fireside Chat at Cantor's "The Future of Oncology" Virtual Symposium (PR Newswire)
Mar-06-23 04:05PM	Precigen Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates (PR Newswire)
Feb-07-23 08:00AM	Precigen Is Pioneering a Nonsurgical Treatment for a Debilitating Respiratory Disease; Positive Data Released on Recurrent Respiratory Papillomatosis Showed a 50% Complete Response (News Direct)
Jan-30-23 02:34PM	Germantown's Precigen raises $75M to advance treatments for rare diseases (American City Business Journals)
Jan-27-23 04:05PM	Precigen Announces Closing of Public Offering of Common Stock (PR Newswire)
Jan-24-23 10:40PM	Precigen Announces Pricing of $75.0 Million Public Offering of Common Stock (PR Newswire)
04:05PM	Precigen Announces Proposed $75.0 Million Public Offering of Common Stock (PR Newswire)
04:01PM	Precigen Announces Positive Phase 1 Dose Escalation and Expansion Cohort Data for Investigational Off-the-Shelf PRGN-2012 AdenoVerse Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (PR Newswire)
Jan-11-23 06:45PM	Precigen Provides Pipeline and Corporate Updates at the 41st Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-04-23 04:05PM	Precigen to Host a Virtual R&D Event on January 24th to Share Safety and Efficacy Data from the Phase 1 Dose Escalation and Expansion Cohorts of PRGN-2012 AdenoVerse Immunotherapy in Recurrent Respiratory Papillomatosis (PR Newswire) +5.41%
Dec-27-22 08:00AM	Precigens Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy (News Direct) -9.29%
Dec-19-22 04:05PM	Precigen to Present at the 41st Annual J.P. Morgan Healthcare Conference (PR Newswire) -5.70%
Dec-12-22 07:01PM	Precigen Announces Positive Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T® Manufactured Overnight for Next Day Infusion in Relapsed or Refractory Acute Myeloid Leukemia Patients (PR Newswire)
Nov-16-22 05:07AM	Bullish: Analysts Just Made A Noticeable Upgrade To Their Precigen, Inc. (NASDAQ:PGEN) Forecasts (Simply Wall St.) -6.15%
Nov-09-22 04:05PM	Precigen Reports Third Quarter 2022 Financial Results and Progress of Clinical Programs (PR Newswire) -8.13%
Nov-02-22 04:30PM	Precigen to Announce Third Quarter 2022 Financial Results on November 9th (PR Newswire)
Sep-21-22 04:30PM	Precigen Names Rutul R. Shah Chief Operating Officer (PR Newswire) -13.81%
Sep-01-22 08:05AM	Precigen to Participate in the 2022 Wells Fargo Healthcare Conference (PR Newswire)
Aug-22-22 08:05AM	Precigen Completes Sale of Non-Healthcare Subsidiary Trans Ova Genetics (PR Newswire)
Aug-08-22 04:05PM	Precigen Reports Second Quarter and First Half 2022 Financial Results (PR Newswire)
Aug-05-22 08:36AM	Investors in Precigen (NASDAQ:PGEN) from five years ago are still down 89%, even after 32% gain this past week (Simply Wall St.)
Aug-01-22 04:05PM	Precigen to Announce Second Quarter and First Half 2022 Financial Results on August 8th (PR Newswire)
Jul-06-22 08:09AM	Reston audience measurement company comScore names its next CEO (American City Business Journals) -9.88%
Jul-05-22 08:05AM	Precigen Enters into Agreement to Divest Non-Healthcare Subsidiary Trans Ova Genetics (PR Newswire) +14.89%
Jun-27-22 04:05PM	Precigen to Participate in the Stifel 2022 Virtual Cell Therapy Summit (PR Newswire)
May-17-22 04:05PM	Precigen to Participate in the 2022 H.C. Wainwright Global Investment Conference (PR Newswire)
May-14-22 08:15AM	Need To Know: Analysts Are Much More Bullish On Precigen, Inc. (NASDAQ:PGEN) Revenues (Simply Wall St.)
May-11-22 06:29AM	Earnings Update: Precigen, Inc. (NASDAQ:PGEN) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts (Simply Wall St.) -7.75%
May-09-22 04:05PM	Precigen Reports First Quarter 2022 Financial Results and Business Updates (PR Newswire) -8.00%
May-02-22 03:00PM	Precigen, Inc. (PGEN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks) +5.26%
Apr-04-22 08:05AM	Precigen Receives Fast Track Designation for PRGN-3006 UltraCAR-T® in Patients with Relapsed or Refractory Acute Myeloid Leukemia (PR Newswire) +11.45%
Apr-03-22 03:40PM	What Type Of Shareholders Make Up Precigen, Inc.'s (NASDAQ:PGEN) Share Registry? (Simply Wall St.)
Mar-01-22 08:00AM	Precigen Reports Fourth Quarter and Full Year 2021 Financial Results (PR Newswire)
Feb-02-22 10:10AM	Further weakness as Precigen (NASDAQ:PGEN) drops 10% this week, taking five-year losses to 88% (Simply Wall St.) -10.38%
Feb-01-22 09:38PM	AGF Investments LLC Buys Health Care Select Sector SPDR, Financial Select Sector SPDR, The ... (GuruFocus.com)
Jan-24-22 02:48PM	It's been a tough year so far on Wall Street. These D.C.-area companies have suffered the biggest hits. (American City Business Journals)
Jan-12-22 04:30PM	Precigen Provides Pipeline and Corporate Updates at the 40th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-11-22 10:00AM	Here's Why Precigen, Inc. (PGEN) Could be Great Choice for a Bottom Fisher (Zacks)
Jan-05-22 04:05PM	Precigen to Present at the 40th Annual J.P. Morgan Healthcare Conference (PR Newswire) -10.47%
Dec-13-21 05:05PM	Precigen Announces Positive Interim Phase 1 Data for PRGN-3006 UltraCAR-T® in Relapsed or Refractory Acute Myeloid Leukemia (PR Newswire)
Dec-01-21 07:56AM	A US$64m market cap addition is just what Precigen, Inc. (NASDAQ:PGEN) insiders like to see after purchasing stock worth US$3.7m (Simply Wall St.)
Nov-24-21 08:38AM	Is the Options Market Predicting a Spike in Precigen (PGEN) Stock? (Zacks) +11.57%
Nov-10-21 04:05PM	Precigen to Present at the Stifel 2021 Virtual Healthcare Conference (PR Newswire) -10.72%
Nov-04-21 09:15AM	Precigen Achieves Significant Clinical Progress for UltraCAR-T® and AdenoVerse Therapies (PR Newswire)
Nov-01-21 03:01PM	Analysts Estimate Precigen, Inc. (PGEN) to Report a Decline in Earnings: What to Look Out for (Zacks) +6.42%
Oct-27-21 04:38PM	Precigen to Host R&D Update Virtual Event on November 4th to Share Clinical Developments (PR Newswire)
Oct-26-21 08:05AM	Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for PRGN-3007 UltraCAR-T® in Advanced ROR1+ Hematological and Solid Tumors (PR Newswire)
Oct-12-21 08:05AM	Precigen Appoints Harry Thomasian Jr. as Chief Financial Officer (PR Newswire)
Oct-05-21 05:00AM	Here are Greater Washington's highest-paid public company CEOs (American City Business Journals)
Oct-04-21 08:34AM	Implied Volatility Surging for Precigen (PGEN) Stock Options (Zacks)
Oct-01-21 08:05AM	Precigen ActoBio Announces Additional Positive Interim Data from Phase 1b/2a Study of AG019 ActoBiotics, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes (PR Newswire)
Sep-21-21 10:55AM	What Kind Of Investors Own Most Of Precigen, Inc. (NASDAQ:PGEN)? (Simply Wall St.)
Sep-01-21 08:05AM	Precigen to Present at the 2021 Wells Fargo Virtual Healthcare Conference and the H.C. Wainwright 23rd Annual Global Investment Conference (PR Newswire)
Aug-09-21 04:01PM	Precigen Reports Second Quarter and First Half 2021 Financial Results (PR Newswire)
Aug-02-21 04:05PM	Precigen to Announce Second Quarter and First Half 2021 Financial Results on August 9th (PR Newswire)
03:01PM	Earnings Preview: Precigen, Inc. (PGEN) Q2 Earnings Expected to Decline (Zacks)
Jun-23-21 05:12AM	If You Had Bought Precigen's (NASDAQ:PGEN) Shares Five Years Ago You Would Be Down 75% (Simply Wall St.)
Jun-10-21 05:05PM	Precigen ActoBio Announces Positive Topline Results from Phase 1b/2a Study of AG019 ActoBiotics, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes (PR Newswire)
04:05PM	Precigen to Present at the JMP Securities Life Sciences Conference (PR Newswire)
May-10-21 04:30PM	Precigen Reports First Quarter 2021 Financial Results (PR Newswire)
Apr-28-21 12:33PM	Precigen, Inc. (PGEN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
Mar-30-21 04:05PM	Precigen Announces Departure of Chief Financial Officer (PR Newswire)
Mar-25-21 05:46AM	How Much Of Precigen, Inc. (NASDAQ:PGEN) Do Insiders Own? (Simply Wall St.)
Mar-23-21 08:05AM	Precigen Announces First Patient Dosed for PRGN-2012 AdenoVerse Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP) (PR Newswire) -5.85%
Mar-18-21 08:30AM	Precigen Receives FDA Orphan Drug Designation for PRGN-2012 AdenoVerse Immunotherapy in Patients with Recurrent Respiratory Papillomatosis (RRP) (PR Newswire) -5.69%
Mar-01-21 04:05PM	Precigen Reports Fourth Quarter and Full Year 2020 Financial Results (PR Newswire)
02:30PM	Precigen, Inc. to Host Earnings Call (ACCESSWIRE)
Feb-22-21 04:05PM	Precigen to Announce Fourth Quarter and Full Year 2020 Financial Results on March 1st (PR Newswire) +5.25%
Feb-04-21 04:05PM	Precigen to Participate in Guggenheim Healthcare Talks Oncology Day (PR Newswire)
Jan-26-21 04:05PM	Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares (PR Newswire) -8.60%

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KIRK RANDAL J	Director	Mar 09 '24	Option Exercise	0.00	213,675	0	32,051,461	Mar 12 05:36 PM
KIRK RANDAL J	Director	Dec 28 '23	Buy	1.41	96,686	136,327	1,096,686	Dec 29 07:30 PM
KINDLER JEFFREY B	Director	Dec 28 '23	Sale	1.41	96,686	136,327	238,275	Dec 29 07:19 PM
MITCHELL DEAN J	Director	Sep 22 '23	Buy	1.41	25,000	35,250	356,836	Sep 25 04:02 PM
Sabzevari Helen	President and CEO	Aug 25 '23	Sale	1.53	76,969	117,763	1,560,004	Aug 25 07:04 PM
Lehr Donald P.	Chief Legal Officer	Aug 24 '23	Sale	1.64	10,947	17,953	428,916	Aug 25 07:03 PM
Thomasian Harry Jr.	Chief Financial Officer	Aug 24 '23	Sale	1.64	9,045	14,834	161,051	Aug 25 06:59 PM
Perez Jeffrey Thomas	SVP, IP Affairs	Aug 24 '23	Sale	1.64	8,891	14,581	458,903	Aug 25 07:00 PM
Shah Rutul R	Chief Operating Officer	Aug 24 '23	Sale	1.64	5,388	8,836	133,474	Aug 25 07:01 PM
Sabzevari Helen	President and CEO	Aug 18 '23	Sale	1.66	55,855	92,719	1,495,386	Aug 18 09:06 PM
Lehr Donald P.	Chief Legal Officer	Aug 17 '23	Sale	1.55	10,762	16,681	418,153	Aug 18 09:13 PM
Thomasian Harry Jr.	Chief Financial Officer	Aug 17 '23	Sale	1.55	8,893	13,784	152,162	Aug 18 09:15 PM
Perez Jeffrey Thomas	SVP, IP Affairs	Aug 17 '23	Sale	1.55	8,741	13,549	448,916	Aug 18 09:18 PM
Shah Rutul R	Chief Operating Officer	Aug 17 '23	Sale	1.55	5,298	8,212	123,382	Aug 18 09:09 PM
KIRK RANDAL J	Director	Aug 16 '23	Buy	1.51	119,411	180,311	31,837,786	Aug 17 08:19 AM
KIRK RANDAL J	Director	Aug 15 '23	Buy	1.52	380,589	577,301	31,718,375	Aug 17 08:19 AM
Hassan Fred	Director	Aug 14 '23	Buy	1.75	570,345	998,104	878,942	Aug 16 04:31 PM
Frank Steven	Director	Aug 14 '23	Buy	1.72	400,000	688,000	882,358	Aug 15 04:18 PM
Sabzevari Helen	President and CEO	Aug 11 '23	Sale	1.44	41,436	59,668	1,409,654	Aug 11 07:24 PM
Lehr Donald P.	Chief Legal Officer	Aug 10 '23	Sale	1.21	11,026	13,341	407,205	Aug 11 07:28 PM
Perez Jeffrey Thomas	SVP, IP Affairs	Aug 10 '23	Sale	1.21	8,956	10,837	438,779	Aug 11 07:26 PM
Thomasian Harry Jr.	Chief Financial Officer	Aug 10 '23	Sale	1.21	6,852	8,291	143,121	Aug 11 07:27 PM
Shah Rutul R	Chief Operating Officer	Aug 10 '23	Sale	1.21	5,429	6,569	113,200	Aug 11 07:29 PM
Sabzevari Helen	President and CEO	Aug 04 '23	Sale	1.10	52,870	58,157	1,309,503	Aug 04 07:05 PM
Lehr Donald P.	Chief Legal Officer	Aug 03 '23	Sale	1.20	10,821	12,985	396,521	Aug 04 07:09 PM
Perez Jeffrey Thomas	SVP, IP Affairs	Aug 03 '23	Sale	1.20	8,789	10,547	428,857	Aug 04 07:10 PM
Thomasian Harry Jr.	Chief Financial Officer	Aug 03 '23	Sale	1.20	6,724	8,069	132,039	Aug 04 07:08 PM
Shah Rutul R	Chief Operating Officer	Aug 03 '23	Sale	1.20	5,328	6,394	103,149	Aug 04 07:06 PM

Open in Screener

AQB

AquaBounty Technologies Inc

Apr 23 • 12:25PM ET

1.81

Dollar change +0.08
Percentage change 4.65	%

Consumer Defensive • Farm Products • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

AQB AquaBounty Technologies Inc daily Stock Chart

Held by: VXF DFAT

Index	-	P/E	-	EPS (ttm)	-7.43	Insider Own	5.64%	Shs Outstand	3.85M	Perf Week	4.02%
Market Cap	6.99M	Forward P/E	-	EPS next Y	-3.10	Insider Trans	0.00%	Shs Float	3.64M	Perf Month	-13.81%
Income	-27.56M	PEG	-	EPS next Q	-1.52	Inst Own	8.76%	Short Float	4.27%	Perf Quarter	-25.21%
Sales	2.47M	P/S	2.83	EPS this Y	36.82%	Inst Trans	-74.58%	Short Ratio	5.97	Perf Half Y	-46.45%
Book/sh	42.89	P/B	0.04	EPS next Y	31.46%	ROA	-13.73%	Short Interest	0.16M	Perf Year	-84.23%
Cash/sh	2.12	P/C	0.85	EPS next 5Y	-	ROE	-15.44%	52W Range	1.57 - 11.90	Perf YTD	-36.49%
Dividend Est.	-	P/FCF	-	EPS past 5Y	17.48%	ROI	-15.93%	52W High	-84.79%	Beta	1.34
Dividend TTM	-	Quick Ratio	0.68	Sales past 5Y	211.08%	Gross Margin	-605.31%	52W Low	15.29%	ATR (14)	0.11
Dividend Ex-Date	-	Current Ratio	0.80	EPS Y/Y TTM	-19.21%	Oper. Margin	-1104.75%	RSI (14)	40.06	Volatility	3.94% 5.65%
Employees	104	Debt/Eq	0.05	Sales Y/Y TTM	-21.18%	Profit Margin	-1114.50%	Recom	3.00	Target Price	3.00
Option/Short	No / Yes	LT Debt/Eq	0.05	EPS Q/Q	-28.32%	Payout	-	Rel Volume	0.19	Prev Close	1.73
Sales Surprise	-20.90%	EPS Surprise	-21.60%	Sales Q/Q	22.69%	Earnings	Apr 01 BMO	Avg Volume	26.01K	Price	1.81
SMA20	-3.74%	SMA50	-15.38%	SMA200	-48.58%	Trades		Volume	2,324	Change	4.65%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-09-21	Upgrade	H.C. Wainwright	Neutral → Buy	$4.50
Oct-08-21	Initiated	ROTH Capital	Buy	$6
Jul-01-21	Initiated	Oppenheimer	Outperform	$7
Mar-10-21	Downgrade	H.C. Wainwright	Buy → Neutral
Mar-04-21	Resumed	Lake Street	Buy	$15
Mar-12-20	Initiated	Lake Street	Buy	$5

Apr-01-24 08:00AM	AquaBounty Technologies Announces Fourth Quarter and Full Year 2023 Financial Results (Newsfile)
Feb-14-24 08:00AM	AquaBounty Technologies Provides Fundraising Update (Newsfile)
Jan-31-24 03:11PM	11 Highest Quality Caviars in the World (Insider Monkey)
Nov-07-23 09:05AM	AquaBounty Technologies Inc (AQB) Reports Q3 2023 Financial Results Amid Market Challenges (GuruFocus.com) +10.86%
08:00AM	AquaBounty Technologies Announces Third Quarter 2023 Financial Results (Newsfile)
08:00AM	Loading…
Oct-13-23 08:00AM	AquaBounty Technologies Announces Reverse Stock Split (Newsfile) -10.87%
Aug-27-23 08:40AM	25 Most Consumed Fish in the US (Insider Monkey)
Aug-14-23 08:00AM	AquaBounty Technologies Announces Promotion of David F. Melbourne Jr. to President (Newsfile)
Aug-01-23 08:00AM	AquaBounty Technologies Announces Second Quarter 2023 Financial Results (Newsfile) -9.56%
Jun-09-23 09:30AM	Fish Consumption by Country Per Capita: Top 20 (Insider Monkey)
Jun-02-23 08:00AM	AquaBounty Announces a Pause to Ohio Farm Construction While It Evaluates Scope Alternatives and a Possible Phased Approach (GlobeNewswire) -16.44%
May-31-23 09:15AM	Favourable Signals For AquaBounty Technologies: Numerous Insiders Acquired Stock \ (Simply Wall St.)
May-04-23 08:00AM	AquaBounty Technologies Announces First Quarter 2023 Financial Results (Newsfile)
Mar-30-23 08:00AM	AquaBounty Technologies Announces Retirement of Richard J. Clothier from Board of Directors (GlobeNewswire)
Mar-07-23 08:00AM	AquaBounty Technologies Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) -10.11%
05:56AM	Loading…
Feb-01-23 05:56AM	Even after rising 19% this past week, AquaBounty Technologies (NASDAQ:AQB) shareholders are still down 54% over the past five years (Simply Wall St.)
Dec-22-22 05:54AM	Director Erin Sharp Just Bought A Handful Of Shares In AquaBounty Technologies, Inc. (NASDAQ:AQB) (Simply Wall St.) +18.97%
Nov-10-22 05:13AM	AquaBounty Technologies Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
Nov-08-22 08:00AM	AquaBounty Technologies Announces Third Quarter Financial Results (GlobeNewswire) -5.04%
Oct-04-22 08:00AM	AquaBounty Announces Receipt of New Withdrawal and Consumptive Use Water Permit from the Ohio Department of Natural Resources (GlobeNewswire) +10.20%
Sep-07-22 08:00AM	AquaBounty Technologies to Host Virtual Analyst Day Presentation on Thursday, September 15, 2022 (GlobeNewswire)
Aug-21-22 10:31AM	Shareholders in AquaBounty Technologies (NASDAQ:AQB) are in the red if they invested five years ago (Simply Wall St.)
Aug-09-22 08:05AM	AquaBounty Technologies, Inc. Announces Second Quarter 2022 Financial Results (GlobeNewswire)
Jun-01-22 10:06AM	Do Institutions Own AquaBounty Technologies, Inc. (NASDAQ:AQB) Shares? (Simply Wall St.) -6.71%
May-20-22 04:05PM	Proxy Advisory Firm ISS Recommends Vote FOR the Charter Amendment Proposal To Increase the Number of Authorized Shares of Common Stock (GlobeNewswire)
May-17-22 04:05PM	AquaBounty Announces Adjournment of Annual Meeting of Stockholders until May 27, 2022 (GlobeNewswire)
May-05-22 08:00AM	AquaBounty Technologies Announces First Quarter 2022 Financial Results (GlobeNewswire) -5.59%
Apr-20-22 08:30AM	AquaBounty Begins Construction of State-of-the-Art, Land-based Salmon Farm with Groundbreaking Ceremony in Pioneer, Ohio (GlobeNewswire)
Mar-10-22 08:30AM	AquaBounty Technologies Announces Results for the Quarter and Year Ended December 31, 2021 (GlobeNewswire) +37.86%
Jan-31-22 08:30AM	AquaBounty Technologies Initiates Site Preparations for Construction of 10,000 Metric Ton Salmon Farm in Pioneer, Ohio (GlobeNewswire) +10.63%
05:38PM	Loading…
Jan-25-22 05:38PM	Epiq Partners, Llc Buys Macquarie Infrastructure Holdings LLC, AquaBounty Technologies Inc, ... (GuruFocus.com)
Jan-11-22 08:30AM	AquaBounty Issues Shareholder Letter and Provides Corporate Update (GlobeNewswire)
Jan-06-22 08:31AM	AquaBounty Technologies to Present at the H.C. Wainwright BioConnect Conference (GlobeNewswire)
Nov-19-21 11:10AM	AQB Stock Alert: Why Shares of AquaBounty Are Taking a Deep Dive Today (InvestorPlace) -20.83%
06:35AM	AquaBounty Stock Plunges As Equity Offering By Selling Shareholders Priced At 32% Discount (Benzinga)
Nov-18-21 09:30PM	AquaBounty Technologies, Inc. Announces Pricing of the Public Secondary Offering of Common Stock by Selling Stockholders (GlobeNewswire) -5.45%
04:01PM	AquaBounty Technologies, Inc. Announces Proposed Public Offering of Common Stock by Selling Stockholders (GlobeNewswire)
Nov-15-21 04:45AM	Does AquaBounty Technologies (NASDAQ:AQB) Have A Healthy Balance Sheet? (Simply Wall St.)
Nov-04-21 08:30AM	AquaBounty Technologies, Inc. Announces Results for the Quarter and Nine Months Ended September 30, 2021 (GlobeNewswire) -6.22%
Nov-02-21 08:30AM	AquaBounty Technologies Provides Progress Update on Planned 10,000 Metric Ton Salmon Farm in Pioneer, Ohio (GlobeNewswire)
Oct-26-21 03:02PM	AquaBounty Technologies, Inc. (AQB) May Report Negative Earnings: Know the Trend Ahead of Q3 Release (Zacks)
Oct-13-21 08:30AM	AquaBounty Announces Launch of Environmental, Social, and Governance (ESG) Integrated Reporting Initiative (GlobeNewswire)
Sep-16-21 06:10AM	Could The AquaBounty Technologies, Inc. (NASDAQ:AQB) Ownership Structure Tell Us Something Useful? (Simply Wall St.)
Sep-09-21 08:30AM	AquaBounty Technologies to Present at Upcoming Investor Conferences in September (GlobeNewswire)
Aug-04-21 08:00AM	AquaBounty Technologies Announces Financial Results for the Quarter and Six Months Ended June 30, 2021 (GlobeNewswire)
Jul-29-21 08:30AM	AquaBounty Technologies Announces Pioneer, Ohio as Location for Planned Salmon Farm (GlobeNewswire)
Jul-18-21 03:12AM	Did AquaBounty Technologies, Inc. (NASDAQ:AQB) Insiders Buy Up More Shares? (Simply Wall St.)
Jun-08-21 01:15PM	Top Agriculture Stocks for Q3 2021 (Investopedia)
Jun-01-21 04:05PM	AquaBounty Announces First Harvest of GE Atlantic Salmon; Receives Approval for the Sale of GE Atlantic Salmon in Brazil (GlobeNewswire) +8.46%
May-19-21 01:56AM	Despite Lacking Profits AquaBounty Technologies (NASDAQ:AQB) Seems To Be On Top Of Its Debt (Simply Wall St.)
May-10-21 04:05PM	AquaBounty Sells Out the First Commercial-Scale Harvest of Genetically Engineered Atlantic Salmon from its Indiana Farm (GlobeNewswire) -6.20%
May-04-21 04:05PM	AquaBounty Technologies Announces First Quarter 2021 Financial Results (GlobeNewswire)
Apr-14-21 02:22PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of AquaBounty Technologies, Inc.- AQB (Newsfile)
Apr-06-21 08:30AM	AquaBounty Hires Dennis Bryant as Director of Sales (GlobeNewswire)
Mar-24-21 12:22PM	Why AquaBounty Technologies Stock Fell Hard Today (Motley Fool) -18.10%
Mar-20-21 03:46AM	Is AquaBounty Technologies, Inc.'s (NASDAQ:AQB) Shareholder Ownership Skewed Towards Insiders? (Simply Wall St.)
Mar-09-21 04:05PM	AquaBounty Technologies Announces Results for the Quarter and Year Ended December 31, 2020 (GlobeNewswire) +9.49%
Feb-26-21 10:07AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of AquaBounty Technologies, Inc.- AQB (Newsfile)
Feb-25-21 08:31AM	AquaBounty Technologies to Attend the Canaccord Genuity 2021 Virtual Sustainability Conference (GlobeNewswire) -7.24%
Feb-11-21 06:00AM	Influencers with Andy Serwer: Sara Menker (Yahoo Finance Video)
Feb-08-21 04:05PM	AquaBounty Technologies, Inc. Announces Closing of $127.1 Million Public Offering of Common Stock, Including Full Exercise of Overallotment Option (GlobeNewswire)
Feb-04-21 01:00PM	Why AquaBounty Technologies Stock Plunged Today (Motley Fool) -13.14%
08:30AM	AquaBounty Technologies, Inc. Announces Pricing of $110.5 Million Public Offering of Common Stock (GlobeNewswire)
Feb-03-21 04:08PM	AquaBounty Technologies, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire) -5.21%
Feb-02-21 01:48PM	Here's Why AquaBounty Technologies Stock Went Up 14% in January (Motley Fool) +9.58%
09:39AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of AquaBounty Technologies, Inc.- AQB (Newsfile)
Jan-14-21 01:18PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of AquaBounty Technologies, Inc.- AQB (Newsfile) +9.86%
Jan-01-21 07:04AM	These 4 Micro-Cap Healthcare Stocks Gained the Most in 2020 (Motley Fool)
Dec-20-20 01:27AM	Insider Buying: The AquaBounty Technologies, Inc. (NASDAQ:AQB) Independent Non-Executive Director Just Bought 16% More Shares (Simply Wall St.)
Dec-14-20 04:05PM	AquaBounty Technologies, Inc. Announces Closing of $65.2 Million Upsized Public Offering of Common Stock, Including Full Exercise of Overallotment Option (GlobeNewswire)
Dec-10-20 11:20AM	Why AquaBounty Stock Was Falling Today After More Than Doubling in Two Weeks (Motley Fool) -19.26%
08:45AM	AquaBounty Technologies, Inc. Announces Pricing of $56.7 Million Upsized Public Offering of Common Stock (GlobeNewswire)
Dec-09-20 04:05PM	AquaBounty Technologies Provides Corporate Update (GlobeNewswire) -5.35%
04:01PM	AquaBounty Technologies, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Nov-06-20 05:23AM	Earnings Update: Here's Why Analysts Just Lifted Their AquaBounty Technologies, Inc. (NASDAQ:AQB) Price Target To US$4.83 (Simply Wall St.)
Nov-05-20 05:43AM	Is AquaBounty Technologies (NASDAQ:AQB) Using Too Much Debt? (Simply Wall St.) +5.10%
Nov-03-20 04:05PM	AquaBounty Technologies, Inc. Announces Results for the Quarter and Nine Months Ended September 30, 2020 and Provides a Corporate Update (GlobeNewswire) +10.11%
Oct-29-20 04:05PM	AquaBounty Technologies, Inc. Announces Mayfield, Kentucky as Potential Location for Planned 10,000 Metric Ton Salmon Farm (GlobeNewswire)
Sep-30-20 05:09PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of AquaBounty Technologies, Inc.- AQB (Newsfile)
Sep-08-20 08:30AM	AquaBounty Technologies to Present at Upcoming Investor Conferences in September (GlobeNewswire) +22.74%
Aug-31-20 06:05PM	LD Micro: 360 Companies Set to Present this Week (ACCESSWIRE)
Aug-24-20 08:30AM	AquaBounty Technologies to Present at LD 500 Virtual Investor Conference (GlobeNewswire)
Aug-20-20 04:05PM	AquaBounty Technologies, Inc. Announces Full Exercise of Over-Allotment Option (GlobeNewswire)
Aug-17-20 09:43AM	2 Strong Buy Stocks Insiders Are Snapping Up (TipRanks) +6.27%
06:12AM	Insider Buying: Randal Kirk Just Spent US$10m On AquaBounty Technologies, Inc. (NASDAQ:AQB) Shares (Simply Wall St.)
Aug-07-20 09:00AM	AquaBounty Technologies, Inc. Announces Pricing of $27.5 Million Public Offering of Common Stock (GlobeNewswire) -17.97%
Aug-06-20 04:45PM	AquaBounty Technologies, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
04:01PM	AquaBounty Technologies Announces Financial Results for the Quarter and Six Months Ended June 30, 2020, and Provides Corporate Update (GlobeNewswire)
Aug-05-20 11:04AM	LD Micro Announces Preliminary List of Presenters for the LD-500. (ACCESSWIRE) -8.65%
06:40AM	What You Need To Know About AquaBounty Technologies, Inc.'s (NASDAQ:AQB) Investor Composition (Simply Wall St.)
Jun-30-20 08:30AM	AquaBounty Commences Commercial Harvest of Conventional Atlantic Salmon Raised in its Land-based Farm in Indiana (GlobeNewswire)
Jun-03-20 09:00AM	47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th (ACCESSWIRE)
08:30AM	AquaBounty Technologies to Present at the June 2020 Virtual Investor Summit (GlobeNewswire)
May-12-20 08:30AM	AquaBounty Technologies Engages MZ Group to Lead Investor Relations and Shareholder Communication Program (GlobeNewswire)
May-07-20 10:10AM	AquaBounty Technologies, Inc. (NASDAQ:AQB) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates (Simply Wall St.) +5.91%
May-05-20 04:05PM	AquaBounty Technologies Provides Corporate Update and First Quarter 2020 Financial Results (GlobeNewswire)
Apr-20-20 06:26AM	Investors Who Bought AquaBounty Technologies (NASDAQ:AQB) Shares Three Years Ago Are Now Down 78% (Simply Wall St.)
Mar-10-20 04:05PM	AquaBounty Technologies, Inc. Announces Results for the Year Ended December 31, 2019 (GlobeNewswire) +6.28%
Mar-01-20 05:49AM	3 Stocks Insiders Are Snapping Up (TipRanks)
Feb-13-20 04:05PM	AquaBounty Technologies, Inc. Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full (GlobeNewswire)

AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. It includes farming of aquatic organisms such as fish, shellfish, crustaceans, and aquatic plants. The firm focuses on a salmon product, a bioengineered Atlantic salmon that can grow to market size faster than conventional farmed Atlantic salmon. The company was founded by Elliot Z. Entis and Garth L. Fletcher on December 17, 1991 and is headquartered in Harvard, MA.

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

PGEN

Precigen Inc

AQB

AquaBounty Technologies Inc

Upgrade your FINVIZ experience